Pharma Blisters Packaging Market
Pharma Blisters Packaging Market, Size, Share, Analysis Report By Product Type (Clamshell, Carded), By Technology Type (Cold Forming, Thermoforming), By Material Type (Polyethylene Terephthalate, HDPE, PVC, LDPE, Aluminum, Paper & Paper Board) By Application - Regional Forecast to 2032
The pharma blister packaging market is estimated to reach US$ 10.5 Bn in 2022 and is projected to reach US$ 19 Bn by 2032, at a 6% CAGR from 2022-2032. Fact.MR - a market research and competitive intelligence provider, envision a moderate growth in demand of pharma blisters packaging market.
The packaging industry is estimated to be valued at around US$ 300 Bn, wherein pharma packaging industry is estimated to account for around 4% of the market share in 2022. Moreover, the blister packaging market is evaluated to reach US$ 15 Bn, in which 70% of the market share will be captured by the pharma blister packing market. However, under the umbrella of the global pharma packaging industry, pharma blisters packaging market accounts for more than 85% of market share and valued around US$ 9.8 Bn in 2020.
The last decade was crucial for pharma industry, as the global market landscape has been revised drastically. Until mid-1990’s U.S, Europe and Japan was catering the 90% of worldwide APIs (Active Pharmaceutical Ingredient) demand. However, evolving market clusters, trade affairs and shifting manufacturing base has turned the table towards the Asia Pacific region in last ten years. As per the recent study, China manufactures more than 40% of all APIs across the globe, nonetheless India and China are the keen source and accounting for more than 75% of APIs imports to US.
Blister packaging is most robust packaging type in pharmaceutical industry as it helps in protecting various pharmaceutical products from factors including air, humidity, and moisture as contact of the products with these factors can lead to contamination. Blister packaging is at the forefront in order to protect medication, improve dosage compliance, and can be easily customized to fit as per the product design. Owing to aforementioned factors, the market is expected to show an optimistic growth pattern over the assessment period.
Pharma Blister Packaging Market Size Value in 2022
US$ ~10.5 Bn
Project Pharma Blister Packaging Market Forecast Value in 2032
US$ ~19 Bn
Global Pharma Blister Packaging Market Growth Rate (2022-2032)
Pharma Blister Packaging Market Share of South Asia & Oceania
Key Companies Profiled
Pharma Blister Packaging Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032
The global pharma blister packaging market has register a promising growth in past half decade of around 5.5% CAGR. Covid-19 has channelized the demand and create ample opportunities for revenue growth, owing to exponential surge in demand for medicines.
Fact.MR- packaging team has scrutinized the market dynamics, key indicators and shifting consumer behavior and regional clusters, this led to extract the growth potential of global pharma blister market. It is been estimated that demand will reach new heights ground at 6% CAGR over the forecast period. The coming years are likely to be prominent for healthcare industry owing to dynamic change in consumer spending behavior and intensified government initiatives, this is presumed to have a subsequent impact on pharma blister packaging demand.
Countries like Germany, Belgium, India, France, US and Spain have exported around 45% of global drugs & medicine during 2018-2021 positioning themselves as market front runners. These prominent countries are expected to navigate demand trajectory over the projection period.
How Eco-Friendly Blister Packaging is Reducing Cost?
In order to minimize carbon footprints and contribute towards green environment, manufacturers are shifting towards sustainability and adopting eco-friendly raw materials for blister packages. For instance, Bilcare Research Inc., a manufacturer of blister packaging launched ECOmply that blends PVC film with special additive to make it biodegradable. Similarly, manufacturers are investing in the research and development activities to develop eco-friendly and cost-effective pharma blister packaging that can withstand thermal, mechanical and biological stress during blister forming process.
Companies have also started procuring eco-friendly blister packaging machines, suitable for packaging products from low-high volume production capabilities. However, using sustainable packaging can be challenging in the pharmaceutical industry where there are stringent safety regulations. Market front runners are undergoing self-assessment in order to develop robust triple bottom line approach for gaining higher profits, streamlining distribution network as well as developing sustainable product portfolio.
How OTC Drugs are Shaping Demand Sphere?
Over-The-Counter (OTC) medications are used as first response to any health issues globally. According to the US Census Bureau, around 58 million people aged 66-84 will be living in U.S. by 2030 and a similar trend of growing old age people across the globe is presumed to be registered. Hence, the consumption of OTC and pharmacy-dispensed drugs is likely to surge. This will have a positive impact on global pharma packaging industry.
Accessibility and affordability are also contributing towards the sales of OTC drugs globally. The concept of generic medicine has created new pathway for revenue growth in densely populated countries like India and ASEAN Countries. High per capita spending on healthcare, advanced regulatory system and growth in aging population are driving pharmaceutical products market in countries like East Asia, Western Europe and North America.
Avail customized purchase options for your needs
Why Smart Blister Packaging has Triggered Demand?
Smart blister packaging is one of megatrends gaining traction in pharma packaging market. Companies are shifting towards smart blister packaging from traditional packaging. Smart blister packs are developed to track the status of drugs during the course of transportation, to combat medical counter-feinting.
Manufacturers are using advanced technology and integrate Radio Frequency Identification (RFID) into blister packs, this simplifies the supply chain process by keeping a track on condition and progress of pharmaceutical products on the move. The RFID tags on blister packs also helps in verifying contents of pack by using a digital code on the ribbon. This eliminates the need to break a tamper-evident seal and also saves time. Emergence of smart packaging has streamlined the supply chain reducing the lead time across the each nodes.
Why U.S Exhibits Enormous Growth Potential?
In the U.S., blister packs are prominently used for packaging of samples of drug products or for packaging OTC drugs. The trend of adhering to the prescribed protocols in the healthcare system in U.S. is likely to influence the North America pharma blister packaging market.
Consumers in U.S. are preferring OTC medicines on a large scale. According to Consumer Healthcare Products Association, on an average, U.S. households spend around US$ 338 per year on OTC medicines. All these factors are likely to contribute towards the rapid growth of pharma blisters packaging in country.
Which Factors are Propelling Japan Pharma Blister Market?
Government interventions in Japan are leading to the growth of generic medicines market in the country. Generic substitution of patent-protected drugs is likely to increase in the coming years. Adaptability to clinical trial dosage and unit dose formats with expanded label content are also increasing in Japan. All these factors are expected to result in significant growth of Japan pharma blister packaging market during the assessment period.
An Adaptive Approach to Modern-day Research Needs
Why Thermoforming Technology is Gaining Momentum?
Thermoforming technology provides comparative upper-edge than cold forming including, safe transit owing to smaller and tightly defined compartments which minimize the risk of damage, visibility due to transparent blister plastic and privilege to enormous customization. Owing to high volume manufacturing capability coupled with reliability, consistency and hygiene makes thermoforming first preference for manufacturers. Low-cost, effective administration and convenience is the key factor which propels the demand for thermoforming technology.
Which Product type is Likely to Maneuver the Growth Curve of Market?
Carded product type is likely to find prominence over the forecast period, practicality, safety, flexibility, marketing exposure and ability to accommodate large number of doses is presumed to bring momentum in demand. Card blister packaging is made up of PVC, PET or PETG which led to provide strength and safeguard from any external damages. Minimal movement in packaging aid to retain the shape of product and at the same time mitigates the risk of damage as well. Carded blister packaging is foresee to exhibit a growth rate of around 6.8% CAGR over the assessment period.
As per pharma blister packaging industry analysis, ACG Pharmapack Pvt. Ltd., Amcor Limited., Bemis Company Inc., Bilcare Research Inc, Constantia Flexibles GmbH, Display Pack, Inc., Honeywell International Inc., Klöckner Pentaplast Group, Rohrer Corporation, Sonoco Products Company, The Dow Company, West Rock Company and Winpak Ltd are prominent manufacturers operating in the market.
Companies are primarily leaned towards product launches and expanding manufacturing facilities across the prominent regions. Collaboration, joint-venture and strategic alliance are often opted by key players to robust their distribution network and regional presence.
Key Segments Covered
- Cold Forming
- Polyethylene Terephthalate (PET, PETE, PETG or polyester)
- High Density Polyethylene (HDPE)
- Polyvinyl Chloride (PVC)
- Low Density Polyethylene (LDPE)
- Paper & Paper Board
- Medical Devices
- FAQs -
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.